EcoLiver’s blood-based test is enabled by a novel platform based on organ-specific Extracellular Vesicles (EVs) for the ...

Welcome to the Nautilus first quarter 2025 earnings conference call. At this time, all participants are in listen-only mode. After the speaker's pressentation, there will be a question and answer ...

Lumos Diagnostics is striving to become the leader in rapid point-of-care tests to distinguish between viral and bacterial ...

Baltimore, MD, 29 April 2025 – Sapio Sciences, the science-aware™ lab informatics platform, announces Sapio Release 25.4, ...

LUND, SE / ACCESS Newswire / April 29, 2025 /BioInvent International AB ("BioInvent") (Nasdaq Stockholm:BINV), a biotech ...

Good afternoon and thank you for joining BridgeBio's Q1 2025 Earnings Conference Call. This is Chinmay Shukla, VP of Strategic Finance at BridgeBio. Today, we will discuss our financial results for ...

A look behind the scenes at one of the city's largest, most exclusive culinary events. Rev, started in 2014, is one of ...

Nautilus Biotechnology, Inc. ( NASDAQ: NAUT) Q1 2025 Earnings Conference Call April 29, 2025 8:30 AM ET Ji-Yon Yi - Head, Investor Relations Sujal Patel - Co-Founder & Chief Executive Officer Parag ...

For some patients, specialist pre-referral advice would let them start treatment in primary care quicker and in turn reduce the pressures on waiting lists. NHS Wales is using technology that allows ...

Nautilus will host a conference call to discuss the first quarter 2025 financial results, business developments and outlook before market open on Tuesday, April 29, 2025, at 5:30 AM Pacific Time / ...

"Returning samples from space is one of the most complex challenges in exploration,” said Intuitive Machines Chief Growth ...